-

Lineage, Inc. (LINE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LINEAGE, INC. (LINE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On April 30, 2025, Lineage reported first quarter 2025 financial results, including that “[t]otal revenue decreased (2.7)%” to $1.29 billion for the quarter. The Company stated it “experienced more normal seasonal trends in the first quarter after multiple years of elevated inventory levels.”

On this news, Lineage’s stock price fell $8.26, or 14.62%, to close at $48.23 per share on April 30, 2025, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Lineage securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com,
Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Contact Us:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:LINE

Release Versions

Contacts

Contact Us:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Law Offices of Howard G. Smith Encourages Innventure, Inc. (INV) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Innventure, Inc. (“Innventure” or the “Company”) (NASDAQ: INV) common stock between November 17, 2025 and August 13, 2026, inclusive (the “Class Period”). Innventure Inc. investors have until October 27, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INNVENTURE, INC. (INV), CONTACT THE LAW OFFICES OF HOWARD...

Law Offices of Howard G. Smith Encourages Flotek Industries, Inc. (FTK) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Flotek Industries, Inc. (“Flotek” or the “Company”) (NYSE: FTK) common stock between August 3, 2026 and August 17, 2026, inclusive (the “Class Period”). Flotek Industries, Inc. investors have until October 26, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FLOTEK INDUSTRIES, INC. (FTK), CONTACT THE LAW OFFICES...

Law Offices of Howard G. Smith Encourages Fractyl Health, Inc. (GUTS) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased acquired Fractyl Health, Inc. (“Fractyl” or the “Company”) (NASDAQ: GUTS) common stock between January 13, 2025 and January 29, 2026, inclusive (the “Class Period”). Fractyl Health, Inc. investors have until October 20, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FRACTYL HEALTH, INC. (GUTS), CONTACT THE LAW...
Back to Newsroom